Achieve Life Sciences, Inc. (ACHV)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Achieve Life Sciences, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Achieve Life Sciences, Inc. (ACHV) has returned -40.85% so far this year and 10.11% over the past 12 months. Over the last ten years, ACHV has returned -46.76% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Oct 13, 1995, ACHV's average daily return is +0.38%, while the average monthly return is +0.43%. At this rate, your investment would double in approximately 13.5 years.

Historically, 47% of months were positive and 53% were negative. The best month was May 2009 with a return of +165.4%, while the worst month was Sep 2007 at -85.7%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 7 months.

On a daily basis, ACHV closed higher 44% of trading days. The best single day was Aug 22, 2008 with a return of +2,825.9%, while the worst single day was Aug 21, 2008 at -94.6%.

Achieve Life Sciences, Inc. has an annualized alpha of 132.97%, beta of 1.07, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since October 16, 1995.

• This stock participated in 191.06% of S&P 500 Index downside but only 25.88% of its upside — more exposed to losses than it benefited from rallies.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

ACHV ranks 47 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The table below present risk-adjusted performance metrics for Achieve Life Sciences, Inc. (ACHV) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Achieve Life Sciences, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Achieve Life Sciences, Inc. was 100.00%, occurring on Apr 8, 2025. The portfolio has not yet recovered.

The current Achieve Life Sciences, Inc. drawdown is 100.00%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Achieve Life Sciences, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Achieve Life Sciences, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.